Regeneron Pharmaceuticals, Inc. (FRA:RGO)
Germany · Delayed Price · Currency is EUR 641.60
-8.20 (-1.26%)
At close: Jan 23, 2026
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of €64.03 billion as of January 30, 2026. Its market cap has decreased by -12.95% in one year.
Market Cap
64.03B
Enterprise Value
50.43B
Revenue
12.22B
Ranking
n/a
PE Ratio
16.69
Stock Price
€641.60
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 64.03B, an increase of 48,625.16%. That is a compound annual growth rate of 20.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 64.03B | -5.07% |
| Dec 31, 2025 | 67.45B | -8.88% |
| Dec 31, 2024 | 74.03B | -12.40% |
| Dec 29, 2023 | 84.50B | 17.20% |
| Dec 30, 2022 | 72.10B | 24.19% |
| Dec 31, 2021 | 58.06B | 39.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |